Multivariate analysis of demographic and clinical characteristics showed a generalized lower odds ratio (OR) in the ITCWM group, including CRP levels and hospitalization duration (OR for CRP levels = 0.976, 95% CI 0.953–0.999, P = 0.043; OR for hospitalization duration = 0.822, 95% CI 0.765–0.884, P < 0.001), suggesting the evident efficacy of TCM in reducing inflammation and hospitalization duration in mild to moderate AP (Table 3). The gene discussed is CRP; the disease is alkaline phosphatase measurement.